const fs = require('fs');
const P = '/home/claude/portfolio_v1/src/data/portfolioData.json';
const data = JSON.parse(fs.readFileSync(P, 'utf8'));
const slug = 'power-bi-pharma-analytics-use-cases-2026';
if (data.blog.items.some(p => p.slug === slug)) { console.log('exists'); process.exit(0); }

const content = `
<p>Pharma and life-sciences companies sit on some of the richest data in any industry — sales and prescription data, supply-chain and cold-chain logs, manufacturing batch records, clinical-trial operations, adverse-event reports, regulatory submissions. Yet in most mid-sized pharma and medtech firms, a surprising amount of it still lives in disconnected spreadsheets and siloed systems, pulled together manually once a month.</p>

<p>That's a huge, expensive gap — and it's exactly what a well-built Power BI layer closes. Here are the six analytics use cases I'd prioritise for any pharma or life-sciences business in 2026, and what a proper dashboard actually delivers for each.</p>

<h2>1. Commercial & field-force analytics</h2>
<p>The biggest BI spend in pharma is usually commercial. Sales teams need to see Rx trends, territory performance, rep effectiveness, and formulary/market access — not in a static monthly PDF, but live.</p>
<p><strong>What a dashboard delivers:</strong> territory and rep scorecards, prescription (Rx) trend analysis, target-vs-achievement, call-plan adherence, and product mix — with drill-through from region → territory → individual rep → account. One source of truth instead of five regional spreadsheets.</p>

<h2>2. Supply chain & cold-chain visibility</h2>
<p>Stock-outs lose revenue; overstock of temperature-sensitive products loses product. Pharma supply chains are unforgiving.</p>
<p><strong>What a dashboard delivers:</strong> inventory and expiry tracking, demand forecasting, batch and lot traceability, distributor/depot stock levels, and cold-chain excursion monitoring. The goal: see a looming stock-out or an expiring batch <em>before</em> it costs you, not in next month's report.</p>

<h2>3. Manufacturing & quality (GxP-aware reporting)</h2>
<p>On the plant side, the questions are about yield, deviations, and right-first-time.</p>
<p><strong>What a dashboard delivers:</strong> batch yield and cycle-time trends, deviation and CAPA tracking, OEE (overall equipment effectiveness), and quality KPIs — built with the data integrity and audit-trail awareness that regulated manufacturing demands. Reporting that stands up to an audit, not just a management review.</p>

<h2>4. Pharmacovigilance & safety signal tracking</h2>
<p>Safety teams are drowning in case volume and regulatory timelines.</p>
<p><strong>What a dashboard delivers:</strong> adverse-event (AE) case intake and backlog, processing timelines vs regulatory deadlines, seriousness and causality breakdowns, and early signal-trend views. It won't replace your safety database — it makes the operational picture visible so nothing slips past a reporting clock.</p>

<h2>5. Clinical trial operations</h2>
<p>This is about running the trial well — not analysing the clinical endpoints (that's for your biostatisticians). The operational layer is where dashboards shine.</p>
<p><strong>What a dashboard delivers:</strong> patient enrolment vs plan, site activation and performance, screen-fail rates, query ageing, and milestone/timeline tracking across sites and studies. A single view of whether the trial is on track, so the clinical ops team isn't rebuilding status decks by hand.</p>

<h2>6. Regulatory & compliance reporting</h2>
<p>Regulatory teams live and die by deadlines and traceability.</p>
<p><strong>What a dashboard delivers:</strong> submission status and timeline tracking, commitment and variation management, audit-finding and CAPA status, and license/registration renewals by market. Built with governed, access-controlled data (RLS so each market sees only its own), and designed with 21 CFR Part 11 / GxP data-integrity principles in mind.</p>

<h2>The compliance reality (and why it matters)</h2>
<p>Pharma BI isn't like e-commerce BI. Data integrity, validated reporting, access control and audit trails aren't nice-to-haves — they're the baseline. A good pharma dashboard is built around a <strong>single governed data model</strong>, with row-level security, documented refresh logic, and a clear data lineage. That's what separates a report leadership <em>trusts</em> from one they quietly double-check in Excel.</p>

<h2>Where to start</h2>
<p>You don't need a two-year transformation programme. For most pharma SMEs and growing biotechs, the highest-ROI first move is one governed dashboard in your most painful area — usually <strong>commercial</strong> or <strong>supply chain</strong> — replacing the monthly manual report. Prove the value there, then expand. That's a 2–4 week engagement, not a platform migration.</p>

<p><em>Work in pharma, medtech or life sciences and still running on spreadsheets? <a href='https://calendly.com/gauravkumarvishwakarma'>Book a free 20-minute discovery call</a> — I'll look at where your data is stuck and tell you the one dashboard that would save the most time first. No pitch, just a straight read.</em></p>
`.trim();

const post = {
  id: 'bp' + Date.now(),
  slug,
  title: 'Power BI for Pharma: 6 Analytics Use Cases Every Life-Sciences Company Should Automate in 2026',
  excerpt: "Pharma sits on some of the richest data anywhere — yet much of it still lives in spreadsheets. Here are the 6 Power BI use cases (commercial, supply chain, quality, PV, clinical ops, regulatory) worth automating first.",
  coverImage: '/images/blog/pharma-analytics.svg',
  tags: ['Pharma', 'Power BI', 'Life Sciences', 'Healthcare Analytics', 'Business Intelligence'],
  author: 'Gaurav Kumar Vishvakarma',
  date: '2026-10-19',
  readingTime: '7 min read',
  featured: false,
  content,
};
data.blog.items.unshift(post);
fs.writeFileSync(P, JSON.stringify(data, null, 2) + '\n', 'utf8');
console.log('Added pharma post | total posts:', data.blog.items.length);
